Quidel Corp (QDEL) 24.54 $QDEL
Quidel to Present at Baird 2014 Health Care Conference
Marketwire - Fri Aug 22, 12:30PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the Baird 2014 Health Care Conference to be held at the New York Palace hotel in New York, NY on Wednesday, September 3, 2014.
Quidel Earnings In Retrospect: Up 10.4% in the Last 20 Days (QDEL)
Comtex SmarTrend(R) - Mon Aug 11, 11:53AM CDT
20 days ago, on July 22nd, 2014, Quidel (NASDAQ:QDEL) reported its earnings. Analysts, on average, expected a loss of $0.11 per share on sales of $30.4 million. The company actually reported a loss of $0.10 per share on sales of $31.5 million, beating EPS estimates by $0.01 and beating revenue estimates by $1.1 million. Since the company's report, shares of Quidel have risen from $22.49 to $24.83, representing a gain of 10.4% in the past 20 days.
Quidel Has Returned 15.2% Since SmarTrend Recommendation (QDEL)
Comtex SmarTrend(R) - Tue Aug 05, 11:06AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on February 3rd, 2014 at $28.70. In approximately 6 months, Quidel has returned 15.18% as of today's recent price of $24.34.
5 Stocks Insiders Love Right Now
at The Street - Wed Jul 30, 10:34AM CDT
Insiders at these companies have been scooping up shares of their own stock lately.
Shares of QDEL Down 18.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Jul 29, 10:03AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on February 3rd, 2014 at $28.70. In approximately 6 months, Quidel has returned 18.57% as of today's recent price of $23.37.
Quidel passes US FDA's clearance to market molecular diagnostic test AmpliVue assay for Group A Strep
M2 - Tue Jul 29, 6:09AM CDT
Diagnostic testing company Quidel (NASDAQ:QDEL) disclosed on Monday the receipt of the US Food and Drug Administration's (FDA) approval to market its AmpliVue GAS Assay for the qualitative detection of Group A ?-hemolytic Streptococcus (Streptococcus pyogenes) nucleic acids isolated from throat swab specimens.
Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep
Marketwire - Mon Jul 28, 8:01AM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received clearance from the United States Food and Drug Administration (FDA) to market its AmpliVue GAS Assay for the qualitative detection of Group A β-hemolytic Streptococcus (Streptococcus pyogenes) nucleic acids isolated from throat swab specimens obtained from patients with signs and symptoms of pharyngitis, such as sore throat.
Quidel (QDEL) Falls: Stock Goes Down 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 7:59AM CDT
Quidel has seen negative earnings estimate revisions for the current year along with a significant decline in its share price for the past one day
Nasdaq stocks posting largest percentage increases
AP - Thu Jul 24, 5:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Quidel (QDEL) is Overbought: Is A Drop Coming? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 7:51AM CDT
Quidel (QDEL) is Overbought: Is A Drop Coming?
Decoding 4 Stocks' Big Earnings Moves
Todd Campbell, The Motley Fool - Motley Fool - Wed Jul 23, 1:05PM CDT
Earnings season is picking up and results are driving big share price pop and drops in companies that are beating or missing on forecasts. Today, ConMed Corp , Quidel Corp . , Neogen , and Vascular Solutions are among health care's biggest...
Upgrade Alert for Quidel (QDEL)
Comtex SmarTrend(R) - Wed Jul 23, 7:59AM CDT
Quidel (NASDAQ:QDEL) was upgraded from Underperform to Neutral at Wedbush today. The stock closed yesterday at $22.49 on volume of 294,000 shares, above average daily volume of 194,000. Quidel Corporation discovers, develops, manufactures, and markets rapid diagnostic products for point-of-care detection of human medical conditions and illnesses. The Company's products provide diagnoses for acute and chronic conditions in the areas of women's health and infectious diseases. Quidel's products are sold to professionals and to consumers.
Quidel Reports Second Quarter 2014 Financial Results
Marketwire - Tue Jul 22, 3:21PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the second quarter ended June 30, 2014.
Quidel Down 24.2% Since SmarTrend Downtrend Call (QDEL)
Comtex SmarTrend(R) - Tue Jul 22, 9:14AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on February 3rd, 2014 at $28.70. In approximately 6 months, Quidel has returned 24.24% as of today's recent price of $21.74.
25.6% Return Seen to Date on SmarTrend Quidel Call (QDEL)
Comtex SmarTrend(R) - Mon Jul 14, 4:56PM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on February 3rd, 2014 at $28.70. In approximately 5 months, Quidel has returned 25.56% as of today's recent price of $21.36.
Quidel to Hold Second Quarter 2014 Financial Results Conference Call on July 22, 2014
Marketwire - Tue Jul 08, 3:15PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will release second quarter 2014 financial results after market close on Tuesday, July 22, 2014.
Downtrend Call Working As Quidel Stock Falls 23.0% (QDEL)
Comtex SmarTrend(R) - Fri Jun 27, 11:31AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on February 3rd, 2014 at $28.70. In approximately 5 months, Quidel has returned 22.95% as of today's recent price of $22.11.
Bear of the Day: Quidel (QDEL) - Bear of the Day
Todd Bunton - Zacks Investment Research - Thu Jun 26, 5:30AM CDT
Bear of the Day: Quidel (QDEL) - Bear of the Day
Quidel to Present at Baird 2014 Health Care Conference
Marketwire - Fri Aug 22, 12:30PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the Baird 2014 Health Care Conference to be held at the New York Palace hotel in New York, NY on Wednesday, September 3, 2014.
Quidel Earnings In Retrospect: Up 10.4% in the Last 20 Days (QDEL)
Comtex SmarTrend(R) - Mon Aug 11, 11:53AM CDT
20 days ago, on July 22nd, 2014, Quidel (NASDAQ:QDEL) reported its earnings. Analysts, on average, expected a loss of $0.11 per share on sales of $30.4 million. The company actually reported a loss of $0.10 per share on sales of $31.5 million, beating EPS estimates by $0.01 and beating revenue estimates by $1.1 million. Since the company's report, shares of Quidel have risen from $22.49 to $24.83, representing a gain of 10.4% in the past 20 days.
Quidel Has Returned 15.2% Since SmarTrend Recommendation (QDEL)
Comtex SmarTrend(R) - Tue Aug 05, 11:06AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on February 3rd, 2014 at $28.70. In approximately 6 months, Quidel has returned 15.18% as of today's recent price of $24.34.
5 Stocks Insiders Love Right Now
at The Street - Wed Jul 30, 10:34AM CDT
Insiders at these companies have been scooping up shares of their own stock lately.
Shares of QDEL Down 18.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Jul 29, 10:03AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on February 3rd, 2014 at $28.70. In approximately 6 months, Quidel has returned 18.57% as of today's recent price of $23.37.
Quidel passes US FDA's clearance to market molecular diagnostic test AmpliVue assay for Group A Strep
M2 - Tue Jul 29, 6:09AM CDT
Diagnostic testing company Quidel (NASDAQ:QDEL) disclosed on Monday the receipt of the US Food and Drug Administration's (FDA) approval to market its AmpliVue GAS Assay for the qualitative detection of Group A ?-hemolytic Streptococcus (Streptococcus pyogenes) nucleic acids isolated from throat swab specimens.
Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep
Marketwire - Mon Jul 28, 8:01AM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received clearance from the United States Food and Drug Administration (FDA) to market its AmpliVue GAS Assay for the qualitative detection of Group A β-hemolytic Streptococcus (Streptococcus pyogenes) nucleic acids isolated from throat swab specimens obtained from patients with signs and symptoms of pharyngitis, such as sore throat.
Quidel (QDEL) Falls: Stock Goes Down 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 7:59AM CDT
Quidel has seen negative earnings estimate revisions for the current year along with a significant decline in its share price for the past one day
Nasdaq stocks posting largest percentage increases
AP - Thu Jul 24, 5:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Quidel (QDEL) is Overbought: Is A Drop Coming? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 7:51AM CDT
Quidel (QDEL) is Overbought: Is A Drop Coming?
Decoding 4 Stocks' Big Earnings Moves
Todd Campbell, The Motley Fool - Motley Fool - Wed Jul 23, 1:05PM CDT
Earnings season is picking up and results are driving big share price pop and drops in companies that are beating or missing on forecasts. Today, ConMed Corp , Quidel Corp . , Neogen , and Vascular Solutions are among health care's biggest...
Upgrade Alert for Quidel (QDEL)
Comtex SmarTrend(R) - Wed Jul 23, 7:59AM CDT
Quidel (NASDAQ:QDEL) was upgraded from Underperform to Neutral at Wedbush today. The stock closed yesterday at $22.49 on volume of 294,000 shares, above average daily volume of 194,000. Quidel Corporation discovers, develops, manufactures, and markets rapid diagnostic products for point-of-care detection of human medical conditions and illnesses. The Company's products provide diagnoses for acute and chronic conditions in the areas of women's health and infectious diseases. Quidel's products are sold to professionals and to consumers.
Quidel Reports Second Quarter 2014 Financial Results
Marketwire - Tue Jul 22, 3:21PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the second quarter ended June 30, 2014.
Quidel Down 24.2% Since SmarTrend Downtrend Call (QDEL)
Comtex SmarTrend(R) - Tue Jul 22, 9:14AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on February 3rd, 2014 at $28.70. In approximately 6 months, Quidel has returned 24.24% as of today's recent price of $21.74.
25.6% Return Seen to Date on SmarTrend Quidel Call (QDEL)
Comtex SmarTrend(R) - Mon Jul 14, 4:56PM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on February 3rd, 2014 at $28.70. In approximately 5 months, Quidel has returned 25.56% as of today's recent price of $21.36.
Quidel to Hold Second Quarter 2014 Financial Results Conference Call on July 22, 2014
Marketwire - Tue Jul 08, 3:15PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will release second quarter 2014 financial results after market close on Tuesday, July 22, 2014.
Downtrend Call Working As Quidel Stock Falls 23.0% (QDEL)
Comtex SmarTrend(R) - Fri Jun 27, 11:31AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on February 3rd, 2014 at $28.70. In approximately 5 months, Quidel has returned 22.95% as of today's recent price of $22.11.
Bear of the Day: Quidel (QDEL) - Bear of the Day
Todd Bunton - Zacks Investment Research - Thu Jun 26, 5:30AM CDT
Bear of the Day: Quidel (QDEL) - Bear of the Day
